Hepatitis A and B Vaccine | TWINRIX - twinrix adult


twinrix adult - TWINRIX [Hepatitis A & Hepatitis B (Recombinant) Vaccine] -GSKSource

Twinrix Adult is indicated for use in non immune adults and adolescents 16 years of age and above who are at risk of both hepatitis A and hepatitis B infection. What is Twinrix Adult? Twinrix Adult is a vaccine, which is available as a suspension for injection. TWINRIX dosing schedules. Standard TWINRIX dosing is 3 vaccine doses over a span of 6 months.. You choose the date for the first dose.The second dose is 1 month after the first and the last dose is 6 months after the first.. A 4-dose rapid schedule is also available for adults 19 years and older.

It is not known whether Twinrix Adult will prevent hepatitis A and hepatitis B in such cases. The vaccine will not prevent infection caused by other agents such as hepatitis C and hepatitis E and other pathogens known to infect the liver. Twinrix Adult is not recommended for Common: ≥ 1/100 to < 1/10. TWINRIX [Hepatitis A & Hepatitis B (Recombinant) Vaccine] is a bivalent vaccine containing the antigenic components used in producing HAVRIX (Hepatitis A Vaccine) and ENGERIX-B [Hepatitis B Vaccine (Recombinant)]. TWINRIX is a sterile suspension for intramuscular administration that contains inactivated hepatitis A virus (strain HM175) and.

TWINRIX ADULT DOSE PLANNER. OPEN Twinrix Adult Dose Planner NOW. HEY TRAVELLER! DOWNLOAD TWINRIX BROCHURE. TWINRIX is a vaccine used in adults, adolescents, children and infants to prevent hepatitis A and B diseases. 100% protection cannot be guaranteed and additional doses may be required. Very common adverse events (>10% of doses) reported in. In some countries outside the United States, notably Canada and Europe, Twinrix is known as Twinrix Adult or AmBirix and a pediatric formulation, called Twinrix Jr or Twinrix Paediatric, is available. Administration schedule. Twinrix can be administered on the same schedule as monovalent Hepatitis B vaccine: at 0- 1- and 6- months. Hepatitis A: Vaccine.